Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFU |
Texto Completo: | https://repositorio.ufu.br/handle/123456789/28520 |
Resumo: | Introduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables. |
id |
UFU_2f0186f4a7c6c1b8859d0efe28ff0db0 |
---|---|
oai_identifier_str |
oai:repositorio.ufu.br:123456789/28520 |
network_acronym_str |
UFU |
network_name_str |
Repositório Institucional da UFU |
repository_id_str |
|
spelling |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mamaCâncer de mamaCitocinasIL-6TNF-alfaLegendPlexReceptores hormonaisSubtipo molecularEstadiamento tumoralGrau tumoralBreast cancerCytokinesHormone receptorsMolecular subtypeTumor stagingTumor gradeCNPQ::CIENCIAS DA SAUDEIntroduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables.Trabalho de Conclusão de Curso (Graduação)Introdução: O câncer de mama é uma das principais causas de morte no mundo, sendo mais frequente nas mulheres. Ele pode ser classificado pelos receptores hormonais, estadiamento, grau, subtipo molecular, metástase e dentre outras variáveis. De um modo geral, as citocinas envolvem um vasto grupo de moléculas que são capazes de evocar efeitos nas células em uma resposta imune e muitas delas estão envolvidas no desenvolvimento do tumor, sendo anti ou pró-tumoral. O TNF-α e a IL-6 têm seu papel dicotômico mostrado em diversos estudos, pois as duas são citocinas pró-inflamatórias e tem como função primordial manter a homeostase do organismo, porém, elas podem assumir um papel pró-tumoral dependendo de uma série de fatores como: tipo do tumor, microambiente tumoral, interferência de outras citocinas, desregulação na sua produção, entre outros. Portanto, estabelecer uma relação entre essas citocinas e alguns fatores clínicos dos pacientes pode fornecer informações importantes para analisar o potencial de biomarcador tumoral dessas citocinas. Objetivo: Esse trabalho teve como objetivo quantificar IL-6 e TNF-afa no soro de pacientes com câncer de mama e analisar sua relação com algumas variáveis clínicas. Metodologia: Foi utilizado a citometria de fluxo com o LegendPlex, um kit que se baseia nos princípios de imunoensaio sanduíche para detectar e quantificar essas citocinas no soro de 80 pacientes com câncer de mama. Resultados: Os resultados obtidos mostram que não há relação entre as citocinas TNF-alfa e IL-6 com as variáveis clínicas. Conclusão: Concluiu-se que não existe uma relação significativa entre as citocinas analisadas e as variáveis clínicas.Universidade Federal de UberlândiaBrasilBiomedicinaSilva, Marcelo José Barbosahttp://lattes.cnpq.br/1896030259489819Botelho, Françoise Vasconceloshttp://lattes.cnpq.br/0523032311499606Borges, Bruna Cristinahttp://lattes.cnpq.br/1239727610132040Silva, Lucas Eduardo Correia da2020-01-27T12:51:51Z2020-01-27T12:51:51Z2019-12-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfSILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020.https://repositorio.ufu.br/handle/123456789/28520porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFUinstname:Universidade Federal de Uberlândia (UFU)instacron:UFU2020-01-28T06:13:00Zoai:repositorio.ufu.br:123456789/28520Repositório InstitucionalONGhttp://repositorio.ufu.br/oai/requestdiinf@dirbi.ufu.bropendoar:2020-01-28T06:13Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)false |
dc.title.none.fl_str_mv |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
title |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
spellingShingle |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama Silva, Lucas Eduardo Correia da Câncer de mama Citocinas IL-6 TNF-alfa LegendPlex Receptores hormonais Subtipo molecular Estadiamento tumoral Grau tumoral Breast cancer Cytokines Hormone receptors Molecular subtype Tumor staging Tumor grade CNPQ::CIENCIAS DA SAUDE |
title_short |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
title_full |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
title_fullStr |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
title_full_unstemmed |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
title_sort |
Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama |
author |
Silva, Lucas Eduardo Correia da |
author_facet |
Silva, Lucas Eduardo Correia da |
author_role |
author |
dc.contributor.none.fl_str_mv |
Silva, Marcelo José Barbosa http://lattes.cnpq.br/1896030259489819 Botelho, Françoise Vasconcelos http://lattes.cnpq.br/0523032311499606 Borges, Bruna Cristina http://lattes.cnpq.br/1239727610132040 |
dc.contributor.author.fl_str_mv |
Silva, Lucas Eduardo Correia da |
dc.subject.por.fl_str_mv |
Câncer de mama Citocinas IL-6 TNF-alfa LegendPlex Receptores hormonais Subtipo molecular Estadiamento tumoral Grau tumoral Breast cancer Cytokines Hormone receptors Molecular subtype Tumor staging Tumor grade CNPQ::CIENCIAS DA SAUDE |
topic |
Câncer de mama Citocinas IL-6 TNF-alfa LegendPlex Receptores hormonais Subtipo molecular Estadiamento tumoral Grau tumoral Breast cancer Cytokines Hormone receptors Molecular subtype Tumor staging Tumor grade CNPQ::CIENCIAS DA SAUDE |
description |
Introduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-10 2020-01-27T12:51:51Z 2020-01-27T12:51:51Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
SILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020. https://repositorio.ufu.br/handle/123456789/28520 |
identifier_str_mv |
SILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020. |
url |
https://repositorio.ufu.br/handle/123456789/28520 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Uberlândia Brasil Biomedicina |
publisher.none.fl_str_mv |
Universidade Federal de Uberlândia Brasil Biomedicina |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFU instname:Universidade Federal de Uberlândia (UFU) instacron:UFU |
instname_str |
Universidade Federal de Uberlândia (UFU) |
instacron_str |
UFU |
institution |
UFU |
reponame_str |
Repositório Institucional da UFU |
collection |
Repositório Institucional da UFU |
repository.name.fl_str_mv |
Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU) |
repository.mail.fl_str_mv |
diinf@dirbi.ufu.br |
_version_ |
1813711368305508352 |